I  The Innovation Factory


     Office Locations:

2905 Premiere Pkwy., Suite 150
Duluth, GA 30097
Phone: 888-935-4411
Fax: 678-417-7325



  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Founded in 1999, The Innovation Factory acquires or licenses technology from laboratories, inventors, and clinicians around which it builds life science ventures. The firm provides all of the necessary business services and support for medical life science start-ups. Unlike the other medical-related 'incubators' nationwide, The Innovation Factory creates, launches and manages its offspring businesses. The Innovation Factory provides the companies it founds with product invention, business formation, financing, staffing, product development, intellectual property development, prototyping, regulatory assistance, and clinical testing. A consortium of venture capital firms has allocated $30 million for The Factory's start-up enterprises. As the start-ups mature, mezzanine financing is available. The firm's venture capital consortium consists of Accuitive Medical Ventures, Versant Ventures, and SV Life Sciences. The Innovation Factory is interested in hearing ideas for therapeutic medical technologies, including the fields of cosmetic surgery, cardiovascular health, orthopedics, neuroscience, and women's health. The team's combined efforts prior to forming The Innovation Factory generated more than $1 billion of shareholder value.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Anthony V. Lando Chief Operating Officer and President
    Charles E. Larsen Vice Chairman
    Cory Anderson VP
    Erin Keller Business Development Associate
    Gordon Wyatt Chief Financial Officer


    Portfolio companies include:

        web link


    Recent News: